(Reuters) The U.S. health regulator on Tuesday issued an emergency use authorization to Roche’s test for the detection of DNA from monkeypox virus in swab specimens collected from people suspected of the virus infection. The tests will be conducted on the Swiss company’s cobas systems, which can also detect HIV, hepatitis B and C viruses. The Food and Drug Administration said testing will be limited to laboratories that meet the requirements to perform moderate or high complexity tests.
Fair Use Notice
UNMC Global Center for Health Security staff curate publicly available news and information for educational and informational purposes. Brief excerpts of published articles may be displayed under principles of Fair Use, with credit and links provided to the source publications. All copyrights remain the property of their respective owners.